Hemophilia Federation observes World Hemophilia Day with MOH&FW

Initiative on Hemophilia Care-II – a sensitization program and the way forward

BCR NEWS (New Delhi):  Every year, the Hemophilia Federation (India) celebrates World Hemophilia Day. This year under the patronage of Ministry of Health & Family Welfare, Govt. of India the day was marked with organizing a workshop on “Initiative on Hemophilia Care II– a sensitization program and the way forward” at India International Center, New Delhi. Key note address was delivered by Ms. Vandana Gurnani, IAS, Joint Secretary, MOH&FW followed by Sh. Manoj Jhalani IAS, Joint Secretary, MOH&FW and Sh. C K Mishra IAS, AS & MD, NHM.

The Guest of Honour, Honourable Smt. Meenakshi Lekhi, MP Lok Sabhan speaking amid august gathering said, “Health is a sate subject but without the support of Central Government the state can  hardly achieve the objectives. I am happy that our Government has finally decided to waive off the customs duty on Anti Hemophilia Factors. This will make the product fairly easy to obtain.”

She also emphasised the need to develop a care system for which she is developing a database Hematological disorders in an around Delhi as a study. While discussing on the issue, she emphasised the need to develop a unified management system for severe Hematological disorders. She further added, “We are trying to get Hemophilia patients for getting sanctioned for benchmark disability or under a special category of disability.” Considering the issue of Hemophilia in women, she hinted about launching a project investigating bleeding orders in women”

Discussing the current state of Hemophilia in India, Dr Kanjaksha Ghosh, President, Hemophilia Federation of India, said, “At present, only 15% of the total Hemophilia population has been identified in India and the rest lay undiagnosed. There are about 16000 patients registered with Hemophilia in the country as yet, however, we suspect that the number of people suffering with Hemophilia in India could be ranging 7 times more than the current registered patients”

The event aimed at generating sensitization on Hemophilia for the policy makers both at national and state level. The daylong session saw representation of senior officials from MOH&FW, State Secretaries of Health, Mission Directors, eminent doctors, hematologists, physiotherapists and hemophilia caregivers from various medical colleges and hospitals of the country.

Talking about the disease management in Delhi region that focusses on providing treatment to patients in their vicinity, Dr Alok Srivastava, Professor, Department of Haematology, CMC Vellore said, “In Delhi, there are 2000 registered patients suffering from Hemophilia and the state is also witnessing cases coming from other states as they do not have basic facilities and management care in their region. Through this initiative, we are proposing to build more “ Hemophilia care centres”  in regions which would create effective mechanism for diagnosis, treatment and bringing timely comprehensive care for Hemophiliacs within their reach. We are committed to provide the treatment accessible and provide state-of-the-art facilities for the patients.”

While talking about the state of Hemophilia in the country and the need of the hour to take appropriate initiatives in collaboration with the government, Dr. Kanjaksha Ghosh added, “We thank the government for their support in establishing infrastructure and providing good quality factors for the management of disease in some parts of the country. However, we need to address this issue at a national level and thus, we would request government intervention at a macro level by means of funding, expanding infrastructural support, making free factors available and building trained workforce to control blood related disorders including Hemophilia”.

According to a study conducted by the World Federation of Hemophilia (Annual Global Survey), almost 50 per cent of the world’s Hemophilia population lives in India and almost 70 per cent of PwH (People with Hemophilia) do not have adequate knowledge or access to treatment. The risk of death from lack of basic knowledge and untreated Hemophilia is very high.

The initiative was supported by Baxalta Biosciences India Private Limited and Novo Nordisk, leading pharmaceutical companies.

About Hemophilia

Hemophilia is a genetic and life-threatening bleeding disorder. Even with a minor injury or cut, in hemophilia patients’ blood does not clot normally due to the absence of clotting proteins called Anti Hemophilia Factors. If not taken care, recurrent and prolonged bleeding into joints and muscles can lead to permanent disability and bleeding from the sensitive organs can lead even to death. The only possible treatment is infusion of life saving drugs called Anti-Hemophilic Factors (AHF), which is costly and neither produced nor readily available in India. (1 unit of Factor costs around Rs. 10-12 and at any bleeding episode a person needs 500 to 2,000 IUs in one shot which amounts to an expenditure of Rs. 5,000 to Rs. 20,000 on an average.)

About Hemophilia Federation (India)

HFI is the only non-profit, self-help organisation working for the welfare of people with Hemophilia. With the network of 80 Chapters spread across the country, we aim to reach out to more and more PWH and provide quality care, affordable treatment, educational & psycho-social support and economic rehabilitation. We have so far been able to identify more than 16,000 hemophiliacs across the country out of estimated 1.2 lacs (i.e. 1 in every 10,000 population).